Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Strong Association Between HIV Incidence and Herpes Simplex Virus Type 2 in Zambia and South Africa: Prospective Data From the HPTN 071 (PopART) Trial.
Bradley J, Floyd S, Piwowar-Manning E, Laeyendecker O, Baker OR, Bell-Mandla N, Bwalya J, Moore A, Eshleman SH, Donnell D, Bock P, Fidler S, Ayles H, Hayes RJ. Bradley J, et al. Among authors: eshleman sh. Open Forum Infect Dis. 2024 Dec 14;12(1):ofae721. doi: 10.1093/ofid/ofae721. eCollection 2025 Jan. Open Forum Infect Dis. 2024. PMID: 39817038 Free PMC article.
HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084.
Fogel JM, Persaud D, Piwowar-Manning E, Richardson P, Szewczyk J, Marzinke MA, Wang Z, Guo X, McCauley M, Farrior J, Tran HV, Ungsedhapand C, Mathew CA, Mpendo J, Rinehart AR, Rooney JF, Cohen MS, Hanscom B, Grinsztejn B, Hosseinipour MC, Delany-Moretlwe S, Landovitz RJ, Eshleman SH; HPTN 083 and HPTN 084 Study Teams. Fogel JM, et al. Among authors: eshleman sh. AIDS Res Hum Retroviruses. 2025 Jan;41(1):30-36. doi: 10.1089/aid.2024.0049. Epub 2024 Oct 28. AIDS Res Hum Retroviruses. 2025. PMID: 39466048
Identification of antibody targets associated with lower HIV viral load and viremic control.
Grant-McAuley W, Morgenlander WR, Ruczinski I, Kammers K, Laeyendecker O, Hudelson SE, Thakar M, Piwowar-Manning E, Clarke W, Breaud A, Ayles H, Bock P, Moore A, Kosloff B, Shanaube K, Meehan SA, van Deventer A, Fidler S, Hayes R, Larman HB, Eshleman SH; HPTN 071 (PopART) Study Team. Grant-McAuley W, et al. Among authors: eshleman sh. PLoS One. 2024 Sep 17;19(9):e0305976. doi: 10.1371/journal.pone.0305976. eCollection 2024. PLoS One. 2024. PMID: 39288118 Free PMC article. Clinical Trial.
Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis.
Landovitz RJ, Delany-Moretlwe S, Fogel JM, Marzinke MA, Piwowar-Manning E, Richardson P, Halvas EK, Mellors JW, Persaud D, Kofron R, McCauley M, Rose S, Rinehart AR, Rooney JF, Adeyeye A, Cohen MS, Donnell D, Hosseinipour MC, Grinsztejn B, Eshleman SH; HPTN 083 and 084 Study Teams. Landovitz RJ, et al. Among authors: eshleman sh. N Engl J Med. 2024 Oct 3;391(13):1253-1256. doi: 10.1056/NEJMc2402088. Epub 2024 Jul 24. N Engl J Med. 2024. PMID: 39046350 Free PMC article. No abstract available.
Evaluation of Xpert point-of-care assays for detection of HIV infection in persons using long-acting cabotegravir for pre-exposure prophylaxis.
Fogel JM, Piwowar-Manning E, Moser A, Hill T, Ahmed S, Cummings V, Mostafa HH, Wang Z, Jennings A, Gallardo-Cartagena JA, Figueroa MI, St Clair M, Rinehart AR, Adeyeye A, Rooney JF, Cohen MS, Grinsztejn B, Landovitz RJ, Eshleman SH; HPTN 083 Study Team. Fogel JM, et al. Among authors: eshleman sh. Microbiol Spectr. 2024 Jul 9;12(8):e0030724. doi: 10.1128/spectrum.00307-24. Online ahead of print. Microbiol Spectr. 2024. PMID: 38980027 Free PMC article.
Performance of the Applied Biosystems HIV-1 Genotyping Kit with Integrase.
Moore HP, Palumbo PJ, Notarte KI, Fogel JM, Cummings V, Gamble T, Del Rio C, Batey DS, Mayer KH, Farley JE, Remien RH, Beyrer C, Hudelson SE, Eshleman SH; HPTN 078 study. Moore HP, et al. Among authors: eshleman sh. J Clin Microbiol. 2024 Jun 12;62(6):e0013624. doi: 10.1128/jcm.00136-24. Epub 2024 May 10. J Clin Microbiol. 2024. PMID: 38727213 Free PMC article.
Demographics of sources of HIV-1 transmission in Zambia: a molecular epidemiology analysis in the HPTN 071 PopART study.
Hall M, Golubchik T, Bonsall D, Abeler-Dörner L, Limbada M, Kosloff B, Schaap A, de Cesare M, MacIntyre-Cockett G, Otecko N, Probert W, Ratmann O, Bulas Cruz A, Piwowar-Manning E, Burns DN, Cohen MS, Donnell DJ, Eshleman SH, Simwinga M, Fidler S, Hayes R, Ayles H, Fraser C; HPTN 071 (PopART) Phylogenetics protocol team; PANGEA consortium. Hall M, et al. Among authors: eshleman sh. Lancet Microbe. 2024 Jan;5(1):e62-e71. doi: 10.1016/S2666-5247(23)00220-3. Epub 2023 Dec 8. Lancet Microbe. 2024. PMID: 38081203 Free PMC article. Clinical Trial.
Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial.
Landovitz RJ, Hanscom BS, Clement ME, Tran HV, Kallas EG, Magnus M, Sued O, Sanchez J, Scott H, Eron JJ, Del Rio C, Fields SD, Marzinke MA, Eshleman SH, Donnell D, Spinelli MA, Kofron RM, Berman R, Piwowar-Manning EM, Richardson PA, Sullivan PA, Lucas JP, Anderson PL, Hendrix CW, Adeyeye A, Rooney JF, Rinehart AR, Cohen MS, McCauley M, Grinsztejn B; HPTN 083 Study Team. Landovitz RJ, et al. Among authors: eshleman sh. Lancet HIV. 2023 Dec;10(12):e767-e778. doi: 10.1016/S2352-3018(23)00261-8. Epub 2023 Nov 9. Lancet HIV. 2023. PMID: 37952550 Free PMC article. Clinical Trial.
Population-level analysis of natural control of HIV infection in Zambia and South Africa: HPTN 071 (PopART).
Grant-McAuley W, Piwowar-Manning E, Clarke W, Breaud A, Zewdie KB, Moore A, Ayles HM, Kosloff B, Shanaube K, Bock P, Meehan SA, Maarman G, Fidler S, Hayes R, Donnell D, Eshleman SH; HPTN 071 (PopART) Study Team. Grant-McAuley W, et al. Among authors: eshleman sh. J Int AIDS Soc. 2023 Oct;26(10):e26179. doi: 10.1002/jia2.26179. J Int AIDS Soc. 2023. PMID: 37886843 Free PMC article. Clinical Trial.
Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial.
Marzinke MA, Hanscom B, Wang Z, Safren SA, Psaros C, Donnell D, Richardson PA, Sullivan P, Eshleman SH, Jennings A, Feliciano KG, Jalil E, Coutinho C, Cardozo N, Maia B, Khan T, Singh Y, Middelkoop K, Franks J, Valencia J, Sanchez N, Lucas J, Rooney JF, Rinehart AR, Ford S, Adeyeye A, Cohen MS, McCauley M, Landovitz RJ, Grinsztejn B; HPTN 083 study group. Marzinke MA, et al. Among authors: eshleman sh. Lancet HIV. 2023 Nov;10(11):e703-e712. doi: 10.1016/S2352-3018(23)00200-X. Epub 2023 Sep 29. Lancet HIV. 2023. PMID: 37783219 Free PMC article. Clinical Trial.
249 results